[Use of probiotics in bacterial vaginosis]
- PMID: 27856152
- DOI: 10.1016/j.semerg.2016.09.002
[Use of probiotics in bacterial vaginosis]
Abstract
Introduction: Bacterial vaginosis (BV) is a change in the vaginal microbiota due to bacterial overgrowth of normal microorganisms, which produces symptoms of vaginal discomfort, increased malodorous vaginal discharge, etc. Although they been seen to improve recurrence rates in clinical practice, the role of probiotics is questioned in these situations. A literature review on BV is presented in order to evaluate the effectiveness of using probiotics as adjuvant therapy in BV.
Method: PubMed, Cochrane and SCOPUS review of the last 5 years publications using probiotics to treat women diagnosed with BV.
Results: An analysis was performed on the 10 items that refer to the use of probiotics in addition to antibiotic treatments.
Conclusions: All items conclude that the use of probiotics is beneficial in cases of BV in addition to conventional treatments. However, the conclusions are not categorical due to there being a wide variety of studies and probiotics used.
Keywords: Bacterial vaginosis; Probiotics; Probióticos; Tratamiento; Treatment; Vaginosis bacteriana.
Copyright © 2016 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Publicado por Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.Arch Gynecol Obstet. 2016 Jan;293(1):101-107. doi: 10.1007/s00404-015-3810-2. Epub 2015 Jul 5. Arch Gynecol Obstet. 2016. PMID: 26142892
-
Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.BMC Infect Dis. 2020 Jul 10;20(1):491. doi: 10.1186/s12879-020-05210-4. BMC Infect Dis. 2020. PMID: 32650729 Free PMC article. Clinical Trial.
-
Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial.Benef Microbes. 2019 Feb 8;10(1):19-26. doi: 10.3920/BM2018.0075. Epub 2018 Dec 10. Benef Microbes. 2019. PMID: 30525953 Clinical Trial.
-
Probiotics in the prevention of recurrences of bacterial vaginosis.Altern Ther Health Med. 2014 Winter;20 Suppl 1:52-7. Altern Ther Health Med. 2014. PMID: 24473986 Review.
-
Bacterial vaginosis: a review on clinical trials with probiotics.New Microbiol. 2013 Jul;36(3):229-38. Epub 2013 Jun 30. New Microbiol. 2013. PMID: 23912864 Review.
Cited by
-
The addition of Lactobacillus spp. negatively affects Mycoplasma bovis viability in bovine cervical mucus.BMC Vet Res. 2020 Jul 20;16(1):251. doi: 10.1186/s12917-020-02454-9. BMC Vet Res. 2020. PMID: 32690006 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical